Circulatory and respiratory effects of the combination medetomidine-ketamine in beagles

J Vet Pharmacol Ther. 1993 Jun;16(2):199-206. doi: 10.1111/j.1365-2885.1993.tb00164.x.

Abstract

The cardiovascular and respiratory parameters of eight laboratory beagles were measured before and after the simultaneous injection of medetomidine (40 micrograms/kg bw) and ketamine (5 mg/bg bw). This combination produced a significant alteration in cardiovascular function. The heart rate, the stroke volume and cardiac output decreased while the systemic vascular resistance increased. These effects were attributed principally to the alpha 2 agonist compound combined with the moderate stimulatory effect of ketamine. The respiratory parameters were little affected by this protocol.

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology*
  • Animals
  • Dogs / physiology*
  • Female
  • Heart / drug effects
  • Heart / physiology
  • Hemodynamics / drug effects*
  • Imidazoles / pharmacology*
  • Ketamine / pharmacology*
  • Male
  • Medetomidine
  • Respiration / drug effects*

Substances

  • Adrenergic alpha-Agonists
  • Imidazoles
  • Ketamine
  • Medetomidine